1998
DOI: 10.1006/jsre.1998.5297
|View full text |Cite
|
Sign up to set email alerts
|

Protection by Cyclosporine A against Normothermic Liver Ischemia-Reperfusion in Pigs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
13
1
1

Year Published

2002
2002
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 14 publications
1
13
1
1
Order By: Relevance
“…In addition, AIF-1 levels were significantly decreased in allografted animals receiving immunosuppression (44). Interestingly animals treated with immunosuppression before ischemia/reperfusion showed ameliorated organ injury (45)(46)(47). The increased concentrations that we found are an indicator of the up-regulation of Kupffer cells after warm ischemic liver injury and a potential involvement of interferon-␥-mediated protein cascades and provide further evidence that ischemia/reperfusion injury may contribute to allograft rejection.…”
Section: Table III Proteins Of the Arachidonic Acid Metabolismsupporting
confidence: 53%
“…In addition, AIF-1 levels were significantly decreased in allografted animals receiving immunosuppression (44). Interestingly animals treated with immunosuppression before ischemia/reperfusion showed ameliorated organ injury (45)(46)(47). The increased concentrations that we found are an indicator of the up-regulation of Kupffer cells after warm ischemic liver injury and a potential involvement of interferon-␥-mediated protein cascades and provide further evidence that ischemia/reperfusion injury may contribute to allograft rejection.…”
Section: Table III Proteins Of the Arachidonic Acid Metabolismsupporting
confidence: 53%
“…This lack of protective CsA effect on CI-WR injury using the ex vivo IPRL model was unexpected and contrasted with previous data reporting amelioration of warm ischemic injury to the liver [9][10][11][12][13]. In some studies, the amelioration was found using very high oral CsA dosages (20 to 30 mg/Kg) and, although blood levels were not reported, toxic levels would have been attained not applicable for human studies [11,12]. We therefore used the in vivo ORLT model in order to determine if our data were not model-dependent.…”
Section: Discussioncontrasting
confidence: 77%
“…The drug exerts its effects primarily by impairing the gene expression in target cells. In addition to its protective effect on grafts, CsA has been reported to ameliorate warm ischemic injury to the liver in different animal species [9][10][11][12][13], as well as warm ischemic injury to other organs [14][15][16]. The protective effects were also reported in isolated cells [17][18][19][20].…”
Section: Introductionmentioning
confidence: 94%
“…We have also shown that only CsA analogs that block transition in isolated mitochondria can offer protection to the reperfused heart Halestrap et al, 1997a). Also, CsA offers reperfusion-injury protection to other tissues, including rat liver (Kurokawa et al, 1992;Shimizu et al, 1994;Travis et al, 1998) and brain (Folbergrova et al, 1997;Shiga et al, 1992;. Also, CsA offers reperfusion-injury protection to other tissues, including rat liver (Kurokawa et al, 1992;Shimizu et al, 1994;Travis et al, 1998) and brain (Folbergrova et al, 1997;Shiga et al, 1992;.…”
Section: Cyclosporinmentioning
confidence: 78%